Material Handler 1
Capricor Therapeutics
Material Handler 1
Capricor Therapeutics
Biotech developing cell- and exosome therapeutics
Salary Range: 21 to 25 (Currency: USD) (Pay period: per-hour-wage)
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.
Biotech developing cell- and exosome therapeutics
Capricor Therapeutics develops cell- and exosome-based therapies for serious diseases. Its products are derived from cells and the tiny particles cells release, aiming to repair or protect tissues in heart disease, Duchenne Muscular Dystrophy, and COVID-19 complications. The company advances these treatments through research and clinical trials to demonstrate safety and effectiveness before pursuing commercialization with hospitals and partners. Its goal is to improve patient outcomes by bringing validated cellular and exosome-based therapies to market and to advance medical science through collaboration.
Explore more opportunities at Capricor Therapeutics